Mesoblast (MESO) Amortization (2017 - 2025)

Mesoblast has disclosed Amortization across 9 years of filings, most recently posting $130.0 million for Q4 2025.

• Amortization for Q4 2025 came in at $130.0 million, up 241.78% year-over-year; the trailing twelve-month figure through Dec 2025 was $392.5 million (up 57.09% YoY), and the FY2025 annual result was $161.6 million, up 156.59% from the prior year.
• Amortization came in at $130.0 million for Q4 2025 at Mesoblast, down from $161.6 million in the prior quarter.
• In the past five years, Amortization ranged from a high of $161.6 million in Q2 2025 to a low of $2.0 million in Q1 2021.
• The 5-year median for Amortization is $77.6 million (2023), against an average of $87.5 million.
• Peak annual rise in Amortization reached 4597.82% in 2021, while the deepest fall reached 96.64% in 2021.
• Mesoblast's Amortization stood at $94.8 million in 2021, then soared by 57.96% to $149.8 million in 2022, then slumped by 48.24% to $77.6 million in 2023, then tumbled by 50.96% to $38.0 million in 2024, then surged by 241.78% to $130.0 million in 2025.
• The last three Amortization figures came in at $130.0 million (Q4 2025), $161.6 million (Q2 2025), and $38.0 million (Q4 2024), per Business Quant data.